Results 241 to 250 of about 2,837,216 (296)

Overcoming impaired antigen presentation in tumor-draining lymph nodes facilitates immunotherapy. [PDF]

J Immunother Cancer
O'Melia MJ, Menzel L, Lei PJ, Zhou H, Zhang X, Contreras-Alvarado N, Rajotte JJ, Liu L, Nikmaneshi MR, Baish JW, Ubellacker JM, Boland GM, Cohen S, Padera TP, Munn LL.   +14 more
europepmc   +1 more source

Mitigating Cancer Therapy–Related Cognitive Impairment by Targeted Activation of Undruggable Phosphatase

Advanced Science, EarlyView.
An RVG‑engineered exosomal saRNA delivery system (RVG‑EVs‑saPtpro) effectively targets and activates hippocampal PTPRO, functioning as a “molecular brake” to alleviate cancer therapy‑related cognitive impairment (CTRCI) by enhancing neuronal survival, neurogenesis, and synaptic plasticity.
Zhimeng Yao, Yuhua Meng, Huanyi Li, Yinhui Jiang, Xiaona Lin, Mengyuan Hu, Qing Liu, Xiaofu Qiu, Hongzheng Ren, Yunlong Pan, Bin Pan, Zexiong Guo, Shuyao Zhang, Dianzheng Zhang, Li Yang, Shegan Gao, Weijing Deng, Jianfan Chen, Hao Zhang   +18 more
wiley   +1 more source

Stress-driven remodeling of antigen presentation and chemokine signaling in pancreatic β-cells: implications for type 1 diabetes. [PDF]

Front Immunol
Mittal R, Alipour F, Doshi J, Mittal M, Hirani K.   +4 more
europepmc   +1 more source

Fibroblast-specific ablation of MHC-I antigen presentation via the IGF2 axis cripples CD8⁺ T cell surveillance in lung cancer. [PDF]

Sci Adv
Song D, Li X, Xiao Q, Tie H, Wu Q, Shi Y, Ye G, Sun J, Liu J, Chen M, Qiu Z, Peng W, Meng L, Ren G, Huang J, Li H.   +15 more
europepmc   +1 more source

DNA damage in macrophages drives immune autoreactivity via nuclear antigen presentation. [PDF]

Nat Aging
Niotis G, Arvanitaki ES, Theodorakis E, Schmalen A, Juretschke T, Argyros O, Tsolis KC, Bertsias G, Drakos E, Beli P, Garinis GA.   +10 more
europepmc   +1 more source

Ferroptotic tumor cells reprogram tumor-associated macrophage antigen presentation to enhance the efficacy of immune checkpoint blockade. [PDF]

Cell Rep Med
Sun JL, Chu YC, Wang F, Yu DD, Liu JR, Xu RC, Liu HH, Qi ZR, Shi X, Yu XN, Yao YK, Liu TT, Weng SQ, Dong L, Shen XZ, Hu SB, Sun T, Zhu JM.   +17 more
europepmc   +1 more source

Correction to "Outer Membrane Vesicles from Caulobacter crescentus: A Platform for Recombinant Antigen Presentation". [PDF]

ACS Nano
Ginez LD, Osorio A, Correal-Medina V, Arenas T, González-Espinosa C, Camarena L, Poggio S.   +6 more
europepmc   +1 more source

Neoself-antigen presentation in SLE: Mordred's coronation in Arthur's absence. [PDF]

Cell Res
Pazhouhandeh M, Sun H, Yu D.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

In vivo antigen presentation

Current Opinion in Immunology, 2004
Monoclonal antibodies specific for defined peptide-MHC complexes are now being used to physically detect T-cell receptor ligands. These reagents have resulted in the identification of the cells that present antigen in lymphoid and non-lymphoid tissues after various forms of antigen administration.
Ronald N, Germain, Marc K, Jenkins
openaire   +2 more sources

Antigen presentation, antigen-presenting cells and antigen processing

Current Opinion in Immunology, 1988
To summarize, during the period under review there have been considerable advances in our understanding of how antigen is associated with MHC on the surface of a presenting cell. Basic rules which govern this association have been confirmed as including both the nature and the configuration of the antigen.
openaire   +2 more sources